MediPharm Labs (TSE:LABS) Shares Up 7.7% – Here’s What Happened

MediPharm Labs Corp. (TSE:LABS)’s stock price shot up 7.7% on Tuesday . The company traded as high as C$0.07 and last traded at C$0.07. 106,847 shares traded hands during mid-day trading, a decline of 37% from the average session volume of 169,924 shares. The stock had previously closed at C$0.07.

MediPharm Labs Stock Up 7.7%

The stock has a fifty day simple moving average of C$0.07 and a two-hundred day simple moving average of C$0.07. The company has a current ratio of 3.21, a quick ratio of 3.10 and a debt-to-equity ratio of 1.45. The firm has a market cap of C$29.45 million, a PE ratio of -2.33 and a beta of -0.29.

MediPharm Labs (TSE:LABS) last released its earnings results on Thursday, November 13th. The company reported C($0.01) earnings per share for the quarter. MediPharm Labs had a negative return on equity of 24.41% and a negative net margin of 30.56%.The firm had revenue of C$11.45 million during the quarter. As a group, sell-side analysts expect that MediPharm Labs Corp. will post -0.04 EPS for the current fiscal year.

MediPharm Labs Company Profile

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.